Update on options for treatment of metastatic castration-resistant prostate cancer

BACKGROUND: Prostate cancer is one of the most common cancers in men in US and European countries. Despite having a favorable prognosis, the incidence of incurable metastatic disease and mortality in the US is about 28,000 per year. Although hormone-based androgen deprivation therapies typically res...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishnu, Prakash, Tan, Winston W
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895780/
https://www.ncbi.nlm.nih.gov/pubmed/20616956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895780/
https://www.ncbi.nlm.nih.gov/pubmed/20616956

Ejemplares similares